2-methoxyestradiol has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, C; Mi, Y; Zhang, Y | 1 |
| Cho, J; Choi, SH; Han, SC; Kim, AR; Kim, J; Kim, JH; Lee, HJ; Lee, YJ; Nam, JK; Park, S | 1 |
| Maxwell, SA; Mukhopadhyay, T; Roth, JA | 1 |
| Huober, JB; Meyn, R; Mukhopadhyay, T; Nakamura, S; Roth, JA | 1 |
4 other study(ies) available for 2-methoxyestradiol and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
2-methoxyestradiol restrains non-small cell lung cancer tumorigenesis through regulating circ_0010235/miR-34a-5p/NFAT5 axis.
Topics: 2-Methoxyestradiol; Carcinogenesis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cell Transformation, Neoplastic; Humans; Lung Neoplasms; MicroRNAs; Transcription Factors | 2023 |
Pharmacologic Inhibition of HIF-1α Attenuates Radiation-Induced Pulmonary Fibrosis in a Preclinical Image Guided Radiation Therapy.
Topics: 2-Methoxyestradiol; Animals; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Hypoxia-Inducible Factor 1, alpha Subunit; Lung Neoplasms; Mice; Pulmonary Fibrosis; Radiation Injuries; Radiotherapy, Image-Guided | 2021 |
Analysis of phosphorylated isoforms of the p53 tumor suppressor protein in human lung carcinoma cells undergoing apoptosis.
Topics: 2-Methoxyestradiol; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; DNA Fragmentation; Electrophoresis, Gel, Two-Dimensional; Estradiol; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasm Proteins; Phosphoproteins; Phosphorylation; Protein Processing, Post-Translational; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1996 |
Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer.
Topics: 2-Methoxyestradiol; Administration, Oral; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Estradiol; Humans; Lung Neoplasms; Neoplasm Proteins; Radiation-Sensitizing Agents; Radiobiology; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2000 |